Direct Inhibition and Down-regulation by Uremic Plasma Components of Hepatic Uptake Transporter for SN-38, an Active Metabolite of Irinotecan, in Humans

Author： Fujita Ken-ichi   Sugiura Tomoko   Okumura Hidenori   Umeda Saki   Nakamichi Noritaka   Watanabe Yusuke   Suzuki Hiromichi   Sunakawa Yu   Shimada Ken   Kawara Kaori   Sasaki Yasutsuna   Kato Yukio  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.31, Iss.1, 2014-01, pp. : 204-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Down-Regulation of Hepatic CYP3A in Chronic Renal Insufficiency

By Rege B.   Krieg R.   Gao N.   Sarkar M.A.  

Pharmaceutical Research, Vol. 20, Iss. 10, 2003-10 ,pp. : 1600-1606

Springer Publishing Company

Access to resources Recommend Favorite

Myocardial -adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity

By Dong E.   Yatani A.   Mohan A.   Liang C.-s.  

European Journal of Pharmacology, Vol. 384, Iss. 1, 1999-11 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

Irinotecan interaction: First report of an interaction with lopinavir/ritonavir leading to elevated irinotecan active metabolite levels: case report

By  

Reactions Weekly, Vol. 1, Iss. 1091, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Determination of irinotecan, SN‐38 and SN‐38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 3, 2013-05 ,pp. : 436-443

Bentham Science Publishers

Access to resources Recommend Favorite